Bon Natural Life LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Bon Natural Life Limited reported a significant net loss for fiscal year 2025, driven by a substantial decrease in total revenue and gross profit, despite strategic shifts in product focus and recent capital raises.
NASDAQ
20-F/A: Bon Natural Life Files Amendment to 20-F, Corrects Typographical Error and Includes Clawback Policy
Bon Natural Life Limited amends its 20-F filing to correct a typographical error and include a copy of the company's clawback policy.
NASDAQ
20-F: Bon Natural Life Limited Reports Fiscal Year 2024 Results: Revenue Declines Amid Strategic Shift
Bon Natural Life Limited's fiscal year 2024 saw a revenue decrease due to changing market dynamics and a strategic focus on bioactive food ingredients.
NASDAQ
Bon Natural Life Limited files an amendment to its 20-F annual report to include information on compliance with home country practices in lieu of certain Nasdaq listing rules.
NASDAQ
Bon Natural Life Limited amends its annual report on Form 20-F to include information on compliance with home country practices in lieu of certain Nasdaq listing rules.
NASDAQ
Bon Natural Life's fiscal year 2023 saw a slight decrease in revenue and a notable decrease in net income due to increased operating expenses and other factors.